Beneficial effect of icodextrin on the hypertriglyceridemia of CAPD patients.
Sisca
Sergio
S
Nephrology and Dialysis Unit, S.M. Annunziata Hospital, Florence, Italy. sisca@dada.it
Maggiore
Umberto
U
D000328:Adult; D000368:Aged; D002784:Cholesterol / Q000097:blood; D015314:Dialysis Solutions / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D005936:Glucans / Q000627:therapeutic use*; D005947:Glucose / Q000627:therapeutic use*; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology*; D000077607:Icodextrin; D007674:Kidney Diseases / Q000097:blood / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D015314:Dialysis Solutions; D005936:Glucans; D014280:Triglycerides; D000077607:Icodextrin; D002784:Cholesterol; D005947:Glucose